1
Country: France | Funding: $219.7M
Enterome is a clinical-stage biopharmaceutical company focused on developing breakthrough immunomodulatory drugs for the treatment of cancer (OncoMimics™ peptides). Enterome’s pioneering approach to drug discovery is based on its unique ability to decode the interaction between the gut microbiome and the immune system.
Enterome is a clinical-stage biopharmaceutical company focused on developing breakthrough immunomodulatory drugs for the treatment of cancer (OncoMimics™ peptides). Enterome’s pioneering approach to drug discovery is based on its unique ability to decode the interaction between the gut microbiome and the immune system.
2
Country: UK | Funding: $205.5M
Pulmocide is focused on the development of inhaled medicines for the treatment of viral and fungal infections of the respiratory tract.
Pulmocide is focused on the development of inhaled medicines for the treatment of viral and fungal infections of the respiratory tract.
3
Country: China | Funding: $195M
Connect Biopharmaceuticals is a developer of novel immune modulators for the treatment of serious autoimmune diseases and inflammation.
Connect Biopharmaceuticals is a developer of novel immune modulators for the treatment of serious autoimmune diseases and inflammation.
4
Country: USA | Funding: $185.9M
AnaptysBio is a therapeutic antibody product company and the leader in the use of somatic hypermutation, or SHM, for antibody discovery and optimization. SHM is the body's natural process for generating potent antibodies to fight disease.
AnaptysBio is a therapeutic antibody product company and the leader in the use of somatic hypermutation, or SHM, for antibody discovery and optimization. SHM is the body's natural process for generating potent antibodies to fight disease.
5
Country: USA | Funding: $177M
GentiBio is a biotherapeutics company developing engineered regulatory T cells (EngTregs) programmed to treat autoimmune allergic diseases.
GentiBio is a biotherapeutics company developing engineered regulatory T cells (EngTregs) programmed to treat autoimmune allergic diseases.
6
Country: USA | Funding: $155M
Third Harmonic Bio is a clinical-stage company developing a first-in-class, highly selective, oral KIT inhibitor.
Third Harmonic Bio is a clinical-stage company developing a first-in-class, highly selective, oral KIT inhibitor.
7
Country: USA | Funding: $24.5M
Nectar builds a comprehensive, vertically integrated allergy healthcare platform leveraging data and clinical research.
Nectar builds a comprehensive, vertically integrated allergy healthcare platform leveraging data and clinical research.
8
Country: Cyprus | Funding: €10M
Liita Care is a MedTech company focused on Respiratory Health. We are committed to improve quality of life for patients and healthy consumers by developing and manufacturing new and better therapies and medical devices for respiratory health management.
Liita Care is a MedTech company focused on Respiratory Health. We are committed to improve quality of life for patients and healthy consumers by developing and manufacturing new and better therapies and medical devices for respiratory health management.
9
Country: USA | Funding: $9M
Sound Health uses acoustic resonance to provide nasal relief.
Sound Health uses acoustic resonance to provide nasal relief.
10
Country: USA | Funding: $5.6M
Allergy Amulet is the world’s smallest and fastest consumer food allergen sensor, testing for common allergenic ingredients in seconds.
Allergy Amulet is the world’s smallest and fastest consumer food allergen sensor, testing for common allergenic ingredients in seconds.
